Presentation: WHO Global Consultation on Transition Towards New and Better Treatments for MDR-TB

Geneva, November 2018

Researchers from endTB participated in the WHO Global Consortium to share updated results and the study’s implementation practices, in addition to evidence to support the transition, operationalization, and scale-up of new MDR-TB guidelines.

_{The following presentations are for individual reference, on behalf of the}_endTB_{study. Data is not yet published or}_{peer reviewed}_.

endTB Clinical Trials (1.27 MB)
endTB Updates from the Observational Study (3.38 MB)
endTB in Lesotho (4.68 MB)
endTB in Kazakhstan: Progress and Transition from Project to Routine Implementation (6.92 MB)
Priorities and Lessons Learned in the endTB Multi-Country Observational Study: Future Analysis Plans (1.47 MB)
Transitioning to new MDR-TB Policy in endTB Project Countries (1.1 MB)
aDSM – Safety of New and Repurposed Drugs; Experience in the endTB Project (6.79 MB)
All-Oral Shorter Regimens for MDR-TB (3.95 MB)
Common Practices of Using New TB Drugs in endTB Project Countries: Prolongation, Concomitant Use and Use in Special Populations (5.51 MB)